- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NVMDF
Recent news which mentions NVMDF
Exclusive: New Latin American JV To Provide More Psychedelic Medical Treatments For Mental Health Conditions
November 22, 2022
From Benzinga
EXCLUSIVE: Bienstar Wellness Starts Treating Patients With Psychedelic Therapy In Brazil, Acquires BRC Saude Mental
July 18, 2022
From Benzinga
Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill
June 15, 2022
From Benzinga
New Acquisition: Novamind To Buy Common Shares Of Numinus Pending Canadian Supreme Court Approval
June 09, 2022
From Benzinga
From Benzinga
Novamind To Offer Ketamine Treatment To Frontline Workers Who Suffer Pandemic-Related Distress
May 19, 2022
From Benzinga
From Benzinga
Novamind And Numinus Prepare For Acquisition, Both Companies Share Info Circulars To Shareholders
May 11, 2022
From Benzinga
From Benzinga
From Benzinga
Numinus Wellness Strives To Become Psychedelic Research Hub After Acquisition Of Novamind Inc.
April 13, 2022
From Benzinga
Numinus to Acquire Novamind For $20.74M In Stock
April 12, 2022
From Benzinga
Core One Labs Begins Trading On OTCQB
April 06, 2022
From Benzinga
EXCLUSIVE: Bienstar Wellness Enters Brazilian Psychedelic Market, Will Acquire Ibogaine Co.
March 29, 2022
Tickers
NVMDF
From Benzinga
From Benzinga
From Benzinga
Novamind Begins Clinical Trial Of Psilocybin For Depression
March 15, 2022
From Benzinga
Psyched: Albert Labs Goes Public, Ex-Moderna Executive Joins MAPS, Novamind and Usona Join For Phase 2 Psilocybin Trial
March 15, 2022
From Benzinga
Novamind Stock Slightly Up On Grants Restricted Share Units
March 11, 2022
Tickers
NVMDF
From Benzinga
Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council
March 09, 2022
From Benzinga
Psyched: First Australian Psych Company On Nasdaq, Utah's Psychedelics Bill, LSD Vs. Psilocybin Study Unprecedented Results
March 07, 2022
From Benzinga
Novamind Posts Record High Revenue Of CA$2.45M, Up 32% QoQ
March 02, 2022
Tickers
NVMDF
From Benzinga
Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th
February 09, 2022
From Benzinga
Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins
February 07, 2022
From Benzinga
Cancer Patients' Case To Use Psilocybin Under Right To Try Law Dismissed By Fed Appeals Court
February 01, 2022
Tickers
NVMDF
From Benzinga
Novamind Expands To Arizona With Purchase Of New Ketamine Clinic
December 23, 2021
Tickers
NVMDF
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.